SBC Medical Group Holdings Incorporated
SBC · NASDAQ
12/31/2024 | 12/31/2023 | 12/31/2022 | |
|---|---|---|---|
| Revenue | $205,416 | $193,542 | $174,161 |
| % Growth | 6.1% | 11.1% | – |
| Cost of Goods Sold | $49,365 | $56,238 | $59,328 |
| Gross Profit | $156,051 | $137,304 | $114,833 |
| % Margin | 76% | 70.9% | 65.9% |
| R&D Expenses | $0 | $0 | $0 |
| G&A Expenses | $67,309 | $66,235 | $93,485 |
| SG&A Expenses | $70,092 | $66,235 | $93,485 |
| Sales & Mktg Exp. | $2,783 | $0 | $0 |
| Other Operating Expenses | $15,655 | $409 | $1,231 |
| Operating Expenses | $85,747 | $66,644 | $94,715 |
| Operating Income | $70,304 | $70,660 | $20,118 |
| % Margin | 34.2% | 36.5% | 11.6% |
| Other Income/Exp. Net | $3,152 | $2,919 | $3,559 |
| Pre-Tax Income | $73,456 | $73,579 | $23,677 |
| Tax Expense | $26,766 | $35,019 | $18,124 |
| Net Income | $46,614 | $39,370 | $6,315 |
| % Margin | 22.7% | 20.3% | 3.6% |
| EPS | 0.483 | 0.418 | 0.037 |
| % Growth | 15.5% | 1,039% | – |
| EPS Diluted | 0.483 | 0.418 | 0.037 |
| Weighted Avg Shares Out | 96,561 | 94,192 | 15,067 |
| Weighted Avg Shares Out Dil | 96,561 | 94,192 | 15,067 |
| Supplemental Information | – | – | – |
| Interest Income | $20 | $87 | $472 |
| Interest Expense | $28 | $45 | $31 |
| Depreciation & Amortization | $3,799 | $12,247 | $5,932 |
| EBITDA | $77,283 | $85,872 | $29,640 |
| % Margin | 37.6% | 44.4% | 17% |